Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis
- Conditions
- Interventions
- First Posted Date
- 2010-01-25
- Last Posted Date
- 2011-07-01
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 255
- Registration Number
- NCT01055106
- Locations
- 🇺🇸
Women's Health Research, Phoenix, Arizona, United States
🇺🇸NEA Women's Clinic, Jonesboro, Arkansas, United States
🇺🇸Miami Research Associates, Miami, Florida, United States
Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery
- First Posted Date
- 2009-05-07
- Last Posted Date
- 2010-08-31
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 247
- Registration Number
- NCT00894647
- Locations
- 🇺🇸
Dermatology Research Associates, Los Angeles, California, United States
🇺🇸Evanston Northwestern Healthcare, Skokie, Illinois, United States
🇺🇸Progressive Clinical Research, San Antonio, Texas, United States
Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts
- Conditions
- Interventions
- First Posted Date
- 2008-08-15
- Last Posted Date
- 2011-07-20
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 511
- Registration Number
- NCT00735462
- Locations
- 🇺🇸
Dermatology Research Associates, Los Angeles, California, United States
🇺🇸PMI Health Research Group, Atlanta, Georgia, United States
🇺🇸Conant Foundation, San Francisco, California, United States
Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts
- Conditions
- Interventions
- First Posted Date
- 2008-05-08
- Last Posted Date
- 2011-05-24
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 470
- Registration Number
- NCT00674739
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center Dermatology Dept, Dallas, Texas, United States
🇺🇸Dermatology Practice, Ann Arbor, Michigan, United States
🇺🇸Alegent Health Clinic, Omaha, Nebraska, United States
Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year
- Conditions
- First Posted Date
- 2008-04-29
- Last Posted Date
- 2010-07-20
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 179
- Registration Number
- NCT00668733
Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)
- First Posted Date
- 2008-01-30
- Last Posted Date
- 2010-06-29
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 479
- Registration Number
- NCT00605176
Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)
- First Posted Date
- 2008-01-29
- Last Posted Date
- 2010-06-29
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 490
- Registration Number
- NCT00603798
Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream
- Conditions
- Interventions
- First Posted Date
- 2006-06-09
- Last Posted Date
- 2010-07-23
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 17
- Registration Number
- NCT00335179
- Locations
- 🇺🇸
Loma Linda University Medical Center, Loma Linda, California, United States
Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2010-08-10
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 169
- Registration Number
- NCT00189306
- Locations
- 🇦🇺
Freemantle Dermatology, Fremantle, Western Australia, Australia
🇦🇺158 South Terrace, Perth, Western Australia, Australia
🇦🇺Skin Centre, Benowa, Queensland, Australia
A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence
- First Posted Date
- 2005-08-12
- Last Posted Date
- 2010-07-16
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 63
- Registration Number
- NCT00129519